Shannon Thyme Klinger Moderna, Inc. (MRNA) insider trading activity

Shannon Thyme Klinger is Chief Legal Officer of Moderna, Inc.. Currently has a direct ownership of 27,483 shares of MRNA, which is worth approximately $698,068. The most recent transaction as insider was on Jun 06, 2025, when has been sold 551 shares (Common Stock) at a price of $26.12 per share, resulting in proceeds of $14,392. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.5K

7.31% 3M change

72.34% 12M change

Total Value Held $698,068

Shannon Thyme Klinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 06 2025	SELL Payment of exercise price or tax liability	$14,392 $26.12 p/Share	551 Reduced 1.97%	27,483 Common Stock
Jun 06 2025	BUY Exercise of conversion of derivative security	-	1,139 Added 3.9%	28,034 Common Stock
May 30 2025	SELL Payment of exercise price or tax liability	$3,043 $26.93 p/Share	113 Reduced 0.43%	26,300 Common Stock
May 30 2025	BUY Exercise of conversion of derivative security	-	233 Added 0.87%	26,413 Common Stock
May 28 2025	SELL Payment of exercise price or tax liability	$4,254 $26.76 p/Share	159 Reduced 0.6%	26,180 Common Stock
May 28 2025	BUY Exercise of conversion of derivative security	-	328 Added 1.23%	26,339 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$9,821 $26.26 p/Share	374 Reduced 1.42%	26,011 Common Stock
May 27 2025	BUY Exercise of conversion of derivative security	-	773 Added 2.85%	26,385 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$18,899 $34.3 p/Share	551 Reduced 2.11%	25,612 Common Stock
Mar 07 2025	BUY Exercise of conversion of derivative security	-	1,139 Added 4.17%	26,163 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$8,487 $31.09 p/Share	273 Reduced 1.08%	25,024 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	562 Added 2.18%	25,184 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$93,318 $33.58 p/Share	2,779 Reduced 10.1%	24,735 Common Stock
Feb 27 2025	BUY Exercise of conversion of derivative security	-	5,747 Added 18.09%	26,018 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$33,033 $30.93 p/Share	1,068 Reduced 4.75%	21,425 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	2,047 Added 8.34%	22,493 Common Stock
Dec 09 2024	SELL Open market or private sale	$23,635 $44.68 p/Share	529 Reduced 2.52%	20,446 Common Stock
Dec 06 2024	BUY Exercise of conversion of derivative security	-	1,138 Added 5.15%	20,975 Common Stock
Dec 03 2024	SELL Open market or private sale	$4,849 $43.3 p/Share	112 Reduced 0.56%	19,837 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	-	232 Added 1.15%	19,949 Common Stock
Nov 29 2024	SELL Open market or private sale	$60,676 $42.79 p/Share	1,418 Reduced 6.71%	19,717 Common Stock
Nov 27 2024	BUY Exercise of conversion of derivative security	-	2,981 Added 12.36%	21,135 Common Stock
Sep 09 2024	SELL Open market or private sale	$40,537 $73.57 p/Share	551 Reduced 2.95%	18,154 Common Stock
Sep 06 2024	BUY Exercise of conversion of derivative security	-	1,139 Added 5.74%	18,705 Common Stock
Sep 03 2024	SELL Open market or private sale	$8,776 $76.99 p/Share	114 Reduced 0.64%	17,566 Common Stock

Also insider at

RFL

Rafael Holdings, Inc. Real Estate

Director

STK